首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2977篇
  免费   182篇
  国内免费   27篇
耳鼻咽喉   9篇
儿科学   74篇
妇产科学   66篇
基础医学   493篇
口腔科学   104篇
临床医学   252篇
内科学   641篇
皮肤病学   34篇
神经病学   336篇
特种医学   117篇
外科学   240篇
综合类   19篇
预防医学   264篇
眼科学   30篇
药学   226篇
中国医学   22篇
肿瘤学   259篇
  2023年   33篇
  2022年   80篇
  2021年   146篇
  2020年   95篇
  2019年   96篇
  2018年   104篇
  2017年   87篇
  2016年   104篇
  2015年   91篇
  2014年   141篇
  2013年   171篇
  2012年   275篇
  2011年   256篇
  2010年   136篇
  2009年   142篇
  2008年   201篇
  2007年   191篇
  2006年   173篇
  2005年   143篇
  2004年   93篇
  2003年   123篇
  2002年   106篇
  2001年   28篇
  2000年   14篇
  1999年   21篇
  1998年   13篇
  1997年   11篇
  1996年   3篇
  1995年   14篇
  1994年   5篇
  1993年   12篇
  1992年   10篇
  1991年   9篇
  1990年   11篇
  1989年   6篇
  1988年   4篇
  1987年   2篇
  1986年   4篇
  1985年   4篇
  1984年   3篇
  1983年   4篇
  1982年   2篇
  1980年   3篇
  1979年   2篇
  1976年   3篇
  1972年   2篇
  1971年   1篇
  1970年   1篇
  1964年   1篇
  1932年   1篇
排序方式: 共有3186条查询结果,搜索用时 15 毫秒
1.

Background

Acute myocardial infarction (AMI) causes irreversible myocardial damage and release of inflammatory mediators, including cytokines, chemokines and miRNAs. We aimed to investigate changes in the levels of cytokines (IL-6, TNF-α and IL-10), miRNAs profiles (miR-146 and miR-155) and distribution of different monocyte subsets (CD14++CD16-, CD14++CD16+, CD14+CD16++) in the acute and post-healing phases of AMI.

Methods

In eighteen consecutive AMI patients (mean age 56.78?±?12.4 years, mean left ventricle ejection fraction – LVEF: 41.9?±?9.8%), treated invasively, monocyte subsets frequencies were evaluated (flow cytometry), cytokine concentrations were analyzed (ELISA) as well as plasma miRNAs were isolated twice – on admission and after 19.2?±?5.9 weeks of follow-up. Measurements were also performed among healthy volunteers.

Results

AMI patients presented significantly decreased frequencies of classical cells in comparison to healthy controls (median 71.22% [IQR: 64.4–79.04] vs. 84.35% [IQR: 81.2–86.7], p?=?0.001) and higher percent of both intermediate and non-classical cells, yet without statistical significance (median 6.54% [IQR: 5.14–16.64] vs. 5.87% [IQR: 4.48–8.6], p?=?0.37 and median 5.99% [IQR: 3.39–11.5] vs. 5.26% [IQR: 3.62–6.2], p?=?0.42, respectively). In AMI patients both, analyzed plasma miRNA concentrations were higher than in healthy subjects (miR-146: median 5.48 [IQR: 2.4–11.27] vs. 1.84 [IQR: 0.87–2.53], p?=?0.003; miR-155: median 25.35 [IQR: 8.17–43.15] vs. 8.4 [IQR: 0.08–16.9], p?=?0.027, respectively), and returned back to the values found in the control group in follow-up. miR-155/miR-146 ratio correlated with the frequencies of classical monocytes (r=0.6, p?=?0.01) and miR-155 correlated positively with the concentration of inflammatory cytokines ? IL-6 and TNF-α.

Conclusions

These results may suggest cooperation of both pro-inflammatory and anti-inflammatory signals in AMI in order to promote appropriate healing of the infarcted myocardium.  相似文献   
2.
3.
4.
5.
6.
7.
Data from 4,300 consecutive cases following prenatal diagnosis by transcervical (TC) CVS (n = (1,570) and transabdominal (TA) CVS (n = 2,370) were evaluated. In the follow-up study only infants examined by a physician were included. Gestational age varied between 8.5 and 11.6 weeks (mean 10.3 weeks) for TC-CVS and between 9.3 and 20 weeks (mean 12.3 weeks) for TA-CVS 98% of TC-CVS was performed at 9–10 weeks, 80.7% of TA-CVS procedures were carried out at 12–15 weeks. Selective termination took place in 97 cases of TC-CVS (6.1%) and in 72 cases of TA-CVS (2.6%). Another 8 Women had a termination for psychosocial reasons, resulting in 4,123 (1,469 TC, 2,645 TA) continuing pregnancies. The overall fetal loss rare <28 weeks was 5.4% (n = 80) for TC-CVS and 2.6% (n = 70) for TA-CVS. The overall incidence of congenital abnormalities after birth was 0.9%. Two terminal transversal limb defects were detected in the TC-CVS group (0.14%) against one (0.04%) in the TA-CVS group. © 1993 Wiley-Liss, Inc.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号